A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI)

por Pinato, D J, North, B V, Sharma, R
Publicado 2012

The expression of Axl receptor tyrosine kinase influences the tumour phenotype and clinical outcome of patients with malignant pleural mesothelioma

por Pinato, D J, Mauri, F A, Lloyd, T, Vaira, V, Casadio, C, Boldorini, R L, Sharma, R
Publicado 2013

Prognostic performance of inflammation-based prognostic indices in primary operable non-small cell lung cancer

por Pinato, D J, Shiner, R J, Seckl, M J, Stebbing, J, Sharma, R, Mauri, F A
Publicado 2014

The systemic pro-inflammatory response: targeting the dangerous liaison between COVID-19 and cancer

por Dettorre, G.M., Patel, M., Gennari, A., Pentheroudakis, G., Romano, E., Cortellini, A., Pinato, D.J.
Publicado 2021

Taxonomic reclassification of Kaposi Sarcoma identifies disease entities with distinct immunopathogenesis

por Openshaw, M. R., Gervasi, E., Fulgenzi, C. A. M., Pinato, D. J., Dalla Pria, A., Bower, M.
Publicado 2023

Inflammation as a validated prognostic determinant in carcinoma of unknown primary site

por Mohamed, Z, Pinato, D J, Mauri, F A, Chen, K-W, Chang, P M-H, Sharma, R
Publicado 2014

An expression signature of the angiogenic response in gastrointestinal neuroendocrine tumours: correlation with tumour phenotype and survival outcomes

por Pinato, D J, Tan, T M, Toussi, S T K, Ramachandran, R, Martin, N, Meeran, K, Ngo, N, Dina, R, Sharma, R
Publicado 2014

Immunohistochemical markers of the hypoxic response can identify malignancy in phaeochromocytomas and paragangliomas and optimize the detection of tumours with VHL germline mutatio...

por Pinato, D J, Ramachandran, R, Toussi, S T K, Vergine, M, Ngo, N, Sharma, R, Lloyd, T, Meeran, K, Palazzo, F, Martin, N, Khoo, B, Dina, R, Tan, T M
Publicado 2013

1596P SERONCOVID: Seroconversion in solid-tumor cancer patients (p) after COVID-19 diagnosis

por Pous, A., Felip, E., Ulazia, O. Etxaniz, Hernández, A., España, S., Marin, M. Romeo, Moran, T., Molina, J.G., Fernandez, G., Pinato, D.J., Esteve, A.M., Mesía, R.
Publicado 2021

Learning lessons from the COVID-19 pandemic for real-world evidence research in oncology—shared perspectives from international consortia

por Castelo-Branco, L., Lee, R., Brandão, M., Cortellini, A., Freitas, A., Garassino, M., Geukens, T., Grivas, P., Halabi, S., Oliveira, J., Pinato, D.J., Ribeiro, J., Peters, S., Pentheroudakis, G., Warner, J.L., Romano, E.
Publicado 2023

319O The systemic pro-inflammatory response identifies cancer patients with adverse outcomes from SARS-CoV-2 infection

por Dettorre, G., Diamantis, N., Loizidou, A., Piccart, M., Chester, J., Jackson, A., Tovazzi, V., Fotia, V., Sita-Lumsden, A., Bower, M., Gaidano, G., Felip, E., Ottaviani, D., Sng, C., Rimassa, L., Santoro, A., Aguilar-Company, J., Seguí, E., Dolly, S., Pinato, D.
Publicado 2020

318O Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients

por Pinato, D.J., Zambelli, A., Bertuzzi, A., Marrari, A., Saoudi-Gonzalez, N., Mirallas, O., Galazi, M., Generali, D., Grisanti, S., Tondini, C., Prat, A., Tabernero, J., Mesia, R., Salazar, R., Sureda, A., Franchi, M., Chiudinelli, L., Illescas, D.G., Libertini, M., Gennari, A.
Publicado 2020

1588P SARS-CoV-2 antibody seroprevalence and safety of vaccines in cancer patients who recovered from COVID-19

por Patel, M., Felip, E., Sharkey, R., Krengli, M., Chester, J.D., Sita-Lumsden, A., Mukherjee, U., Russell, B., Loizidou, A., Colomba, J., Cruz, C. Andrea, Cabirta, A., Camps, I. Ruiz, Brunet, J., Sureda, A., Patriarca, A., Tondini, C., Pinato, D.J., Cortellini, A.
Publicado 2021

1565MO Time-dependent improvement in the clinical outcomes from COVID-19 in cancer patients: An updated analysis of the OnCovid registry

por Pinato, D.J., Patel, M., Lambertini, M., Colomba, E., Pommeret, F., Van Hemelrijick, M., Zambelli, A., Newsom-Davis, T., Salazar, R., Bertuzzi, A., Gaidano, G., Rizzo, G., Patel, G., Felip, E., Prat, A., Aguilar-Company, J., Tabernero, J., Diamantis, N., Gennari, A., Cortellini, A.
Publicado 2021

1560O Prevalence and impact of COVID-19 sequelae on treatment pathways and survival of cancer patients who recovered from SARS-CoV-2 infection

por Cortellini, A., Roldán, E., Garcia, M.C. Carmona, Berardi, R., Sánchez, A., Martinez, C., Parisi, A., Jones, E., Bertulli, R.M., Rizzo, G., Guida, A., Chung, C., Bower, M.D., Betti, M., Vincenzi, B., Mirallas, O., Biello, F., Queirolo, P., Gennari, A., Pinato, D.J.
Publicado 2021

1671MO Provision of palliative care for patients with cancer and SARS-CoV-2 infection

por Soosaipillai, G.B., Sureda, A., Maluquer Artigal, C., Benafif, S., Chopra, N., Harbeck, N., Wuerstlein, R., Mesia Nin, R., Felip, E., Ottaviani, D., Galazi, M., Lee, A.J.X., Salazar, R., Sharkey, R., Reyes, R., Evans, J., Carmona Garcia, M.C., Tabernero, J., Prat, A., Pinato, D.J.
Publicado 2020

1679P Determinants of mortality from SARS-CoV-2 infection in European cancer patients

por Pinato, D.J., Sng, C., Wong, Y.N.S., Biello, F., Seguí, E., Aguilar-Company, J., Carbo Bague, A., Patriarca, A., Bower, M.D., Rizzo, G., Bruna, R., Cruz, C.A., D'Avanzo, F., Newsom-Davis, T., Mollà, M., Gaidano, G., Brunet, J., Tabernero, J., Prat, A., Gennari, A.
Publicado 2020

237P Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: A joint analysis of OnCovid and ESMO-CoCARE registries

por Cortellini, A., Dettorre, G., Dafni, U., Aguilar Company, J., Castelo-Branco, L., Lambertini, M., Gennatas, S., Rogado, J., Vinal Lozano, D., Harrington, K.J., Tsourti, Z., Michielin, O.A., Pommeret, F., Brunet Vidal, J.M., Tabernero, J., Pentheroudakis, G., Gennari, A., Peters, S., Romano, E., Pinato, D.J.
Publicado 2022

504P SARS-CoV-2 Omicron (B.1.1.529) variant infection leads to high morbidity and mortality in unvaccinated patients with cancer

por Pinato, D.J., Aguilar-Company, J., Bertuzzi, A., Hanbury, G.H., Bower, M.D., Salazar, R., Lambertini, M., Pedrazzoli, P., Lee, A.J.X., Sinclair, A., Townsend, S., Plaja Salarich, A., Sita-Lumsden, A.R., Mukherjee, U., Diamantis, N., Sharkey, R., Gaidano, G., Gennari, A., Tabernero, J., Cortellini, A.
Publicado 2022

Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis

por Rimini, M., Rimassa, L., Ueshima, K., Burgio, V., Shigeo, S., Tada, T., Suda, G., Yoo, C., Cheon, J., Pinato, D.J., Lonardi, S., Scartozzi, M., Iavarone, M., Di Costanzo, G.G., Marra, F., Soldà, C., Tamburini, E., Piscaglia, F., Masi, G., Cabibbo, G., Foschi, F.G., Silletta, M., Pressiani, T., Nishida, N., Iwamoto, H., Sakamoto, N., Ryoo, B.-Y., Chon, H.J., Claudia, F., Niizeki, T., Sho, T., Kang, B., D’Alessio, A., Kumada, T., Hiraoka, A., Hirooka, M., Kariyama, K., Tani, J., Atsukawa, M., Takaguchi, K., Itobayashi, E., Fukunishi, S., Tsuji, K., Ishikawa, T., Tajiri, K., Ochi, H., Yasuda, S., Toyoda, H., Ogawa, C., Nishimur, T., Hatanaka, T., Kakizaki, S., Shimada, N., Kawata, K., Tanaka, T., Ohama, H., Nouso, K., Morishita, A., Tsutsui, A., Nagano, T., Itokawa, N., Okubo, T., Arai, T., Imai, M., Naganuma, A., Koizumi, Y., Nakamura, S., Joko, K., Iijima, H., Hiasa, Y., Pedica, F., De Cobelli, F., Ratti, F., Aldrighetti, L., Kudo, M., Cascinu, S., Casadei-Gardini, A.
Publicado 2022